ClariVest Asset Management’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-7,064
Closed -$2.3M 947
2024
Q1
$2.3M Sell
7,064
-2,720
-28% -$668K 0.24% 116
2023
Q4
$1.86M Sell
9,784
-3,555
-27% -$672K 0.1% 139
2023
Q3
$2.66M Sell
13,339
-613
-4% -$145K 0.14% 102
2023
Q2
$3.98M Sell
13,952
-3,219
-19% -$894K 0.2% 81
2023
Q1
$3.72M Buy
17,171
+6
+0% +$1.17K 0.17% 111
2022
Q4
$3.53M Sell
17,165
-51
-0.3% -$12.9K 0.17% 107
2022
Q3
$4.79M Sell
17,216
-3,333
-16% -$848K 0.23% 86
2022
Q2
$3.93M Buy
20,549
+9,781
+91% +$1.73M 0.17% 105
2022
Q1
$2.23M Buy
10,768
+2,378
+28% +$392K 0.09% 204
2021
Q4
$1.5M Buy
8,390
+669
+9% +$132K 0.05% 266
2021
Q3
$1.59M Sell
7,721
-117
-1% -$23K 0.05% 259
2021
Q2
$1.49M Buy
+7,838
New +$1.28M 0.05% 241

Other funds holding SWAV

ClariVest Asset Management's SWAV Position: Q2 2024 in Review

ClariVest Asset Management sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q2 2024, closing a stake of 7,064 shares — an estimated $2.3M sold.

ClariVest Asset Management first reported a position in SWAV in Q2 2021 and held it in 12 quarters. The position peaked at $4.79M in Q3 2022. 7 funds tracked by Wall St. Rank hold SWAV as of Q2 2024.

  • ClariVest Asset Management reported no remaining Shockwave Medical, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • ClariVest Asset Management sold 7,064 Shockwave Medical, Inc. Common Stock shares in Q2 2024, an estimated $2.3M.
  • ClariVest Asset Management first reported a position in Shockwave Medical, Inc. Common Stock in Q2 2021 and held it in 12 quarters.
  • ClariVest Asset Management's Shockwave Medical, Inc. Common Stock position peaked at $4.79M in Q3 2022.
  • 7 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q2 2024.

Based on ClariVest Asset Management's 13F filing for Q2 2024, filed 7 Aug 2024.